CREKA-YpFFK (Nph)
CREKA-YpFFK (Nph) is a gold nanoparticle surface ligand composed of CREKA and YPFFK (Nph), responsible for tumor targeting and alkaline phosphatase-responsive bond cleavage, respectively. CREKA-YpFFK (Nph) can be used for tumor targeting research[1].
Product Specifications
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(N[C@H](CCCNC(N)=N)C(N[C@H](CCC(O)=O)C(N[C@H](CCCCN)C(N[C@H](C)C(N[C@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(N[C@H](CC2=CC=CC=C2)C(N[C@H](CC3=CC=CC=C3)C(N[C@H](CCCCN4C(C5=CC=CC6=C5C(C4=O)=CC=C6N7CCOCC7)=O)C(N)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CS)N
Molecular Formula
C72H95N16O18PS
Molecular Weight
1535.66
References & Citations
[1]Chang X, et al. Tumor Diagnosis and Treatment Based on Stimuli-Responsive Aggregation of Gold Nanoparticles. Exploration (Beijing) . 2025 Feb 6;5 (3) :270006.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 